Ariceum Therapeutics establishes subsidiary in Basel The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel…martin02.09.2023
RocketVax raises fresh capital The Basel-based biotech startup RocketVax has successfully closed another financing round. This additional funding will primarily be used to further…martin02.07.2023
Clinerion is now part of Citeline Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with…martin02.02.2023
KUORI developing biodegradable plastics The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of…martin01.27.2023
Cell and gene therapies gain momentum in Basel Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the…martin01.23.2023
BLKB expanding support for startups BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies…martin01.12.2023
Combatting the rise of antimicrobial resistance Antimicrobial resistance is a growing global threat that, without intervention, could lead to as many as 10 million deaths annually…martin01.11.2023
AMR Action Fund invests in new antibiotics developed by BioVersys The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The…martin01.06.2023
Investors give Resistell 8.5 million Swiss francs Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology…martin12.23.2022
BSI integrating AI from Parashift in banking software Parashift, the specialist in the area of smart document processing on the basis of Artificial Intelligence (AI), has entered into…martin12.16.2022